MyAverix Finance
SA · Healthcare
Neurocrine Biosciences Inc. (N1BI34)
Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc. (N1BI34) is listed on SA in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $68.59B, P/E ratio is 28.01, net margin is 16.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for N1BI34
Neurocrine Biosciences Inc. (N1BI34) — FAQ
What is Neurocrine Biosciences Inc.'s market cap?
Neurocrine Biosciences Inc. (N1BI34) has a reported market cap of $68.59B (data as of 2026-03-29).
What is N1BI34's P/E ratio?
The price-to-earnings (P/E) ratio for Neurocrine Biosciences Inc. (N1BI34) is 28.01 (data as of 2026-03-29).
Does Neurocrine Biosciences Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Neurocrine Biosciences Inc. (N1BI34). Check the MyAverix Finance app for the latest dividend data.
What sector is Neurocrine Biosciences Inc. in?
Neurocrine Biosciences Inc. (N1BI34) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is N1BI34 listed on?
N1BI34 is listed on SA.
What is Neurocrine Biosciences Inc.'s net margin?
Neurocrine Biosciences Inc. (N1BI34) reports a net margin of 16.7% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.